About company
The strategy of Lokon is to modulate the tumor microenvironment and simultaneously activate the immune system to attack the tumor using immunostimulatory gene therapy.
- US
- angelica.loskog@nxt2b.com
- Unknown
- lokonpharma.com/
- Not verified company
